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A B S T R A C T
Adoption of routine cervical cancer screening in Malawi is very low, even though it has the highest cervical
cancer burden in the world. We performed a multi-level assessment of Malawian women’s knowledge and
perceptions of cervical cancer risk and screening. Using the Multi-Level Health Outcomes Framework, we
conducted interviews with 60 adult Malawian women aged 18–62 at facilities with cervical cancer screening.
Eligible participants were recruited regardless of HIV status or history of screening, and asked about their ex-
periences with cervical cancer disease and screening. Interviews were audio recorded and a theory-informed
codebook was developed. Analysis focused on thematic differences across groups by age, HIV status, and
screening history. Half of the sample (n = 30) had either never been screened for cervical cancer or were at the
facility for their first-ever screen. Most women said that cervical cancer is dangerous, and many knew someone
affected. Many women spoke about the importance of screening for prevention of cancer. Risk factors were
generally well-understood, including increased risk with HIV, although this was misunderstood by some HIV-
negative women to mean they were not at risk. Social networks were identified as a key determinant of
screening, and gender issues were likewise highly salient. Despite high knowledge levels about cervical cancer,
there remain significant challenges to improving screening, including interpersonal and system-level barriers.
Future work should strengthen service delivery, target social networks and intimate partners, and develop
targeted communication strategies for HIV-positive and -negative groups, especially in high-burden settings.
1. Introduction
Cervical cancer is a major cause of disease and death in many low-
income countries. Prevention strategies have effectively reduced the
burden in high-income countries, and this has caused a highly in-
equitable global distribution of disease: “cervical cancer is not a disease
of the past – it is a disease of the poor” (Knaul et al., 2019). Malawi has
the highest age-standardized cervical cancer incidence and mortality in
the world (Bray et al., 2018): 72.7 cases per 100,000 women, and 53.9
deaths per 100,000 women (in the United States, there are 6.4 cases and
1.8 deaths per 100,000 women) (Bray et al., 2018).
Some studies indicate that fewer than 10% of Malawian women
have ever been screened for cervical cancer (Gakidou et al., 2008;
Reddy et al., 2014). Additionally, since women with HIV are at higher
risk for cervical dysplasia and progression to invasive cancer (Dryden-
Peterson et al., 2016; Franceschi and Jaffe, 2007), Malawi’s high HIV
prevalence (approximately 12% of adult women are HIV-positive)
(National Statistical Office Malawi and ICF, 2017; UNAIDS, 2017)
presents another risk factor (Cubie et al., 2017; Reddy et al., 2014).
Malawi utilizes a single-visit “screen and treat” strategy for sec-
ondary prevention of cervical cancer (Ministry of Health Malawi, 2014;
The Government of Malawi Ministry of Health, 2017; World Health
Organization, 2013): women are examined for precancerous lesions
using visual inspection with acetic acid (VIA), and eligible lesions are
removed immediately (women with more advanced disease are referred
for specialty care). The global health development assistance commu-
nity has recently increased its investments in cervical cancer prevention
in Malawi (GAVI, 2019; PEPFAR, 2018).
The scale-up of cervical cancer prevention programs in Malawi
presents a new opportunity to strengthen our understanding of what
women think, believe, perceive and experience about cervical cancer
and “screen and treat” programs. Previous qualitative studies with
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Malawian women have found low awareness about cervical cancer risk,
low perceived susceptibility, and many misconceptions about the role
and process of screening (Fort et al., 2011; Hami et al., 2014; Ports
et al., 2015). A more recent (2016) quantitative survey in Malawi
suggested increased knowledge about the efficacy of “screen and treat”
and an evolving understanding of risk factors, as compared to prior
studies (Maree and Kampinda-Banda, 2018). Literature reviews have
identified similar determinants of cervical cancer screening in low- and
middle-income countries (knowledge about the disease and efficacy of
screening and treatment, perceived severity and susceptibility)
(Adewumi et al., 2019; Black et al., 2019; Chan et al., 2015;
Chidyaonga-Maseko et al., 2015; Lim and Ojo, 2017; McFarland et al.,
2016). Some of these themes have not been identified in the literature
from Malawi, including interpersonal influences and spousal support;
nor the intersection of cervical cancer and HIV, despite the unique
challenges and opportunities these dual epidemics may present. The
goal of this study was to explore Malawian women’s perceptions of and
experiences with cervical cancer disease and screening, using a theory-
informed qualitative design.
2. Methods
Theoretical framework: We use the Multi-Level Health Outcomes
Framework (MHOF; previously Health Behavior Framework) to ex-
amine how cervical cancer screening behavior is affected by patient-
level factors, including knowledge and beliefs (about cervical cancer,
susceptibility, efficacy of screening), barriers and facilitators, and cues
to action (Fig. 1) (Bastani et al., 2010). The MHOF takes a socio-eco-
logical perspective and synthesizes common health behavior, outcomes,
and implementation science constructs – to consider the range of factors
that may affect health behaviors, although the framework acknowl-
edges that, practically, a single study will generally focus on only a sub-
set of model factors. The MHOF situates the individual-level factors
explored here within a broader context that likewise influences health
behaviors and health outcomes. The MHOF has been used for formative
research, instrument development, and intervention design targeting
diverse groups in varied contexts, including previous research in liver
cancer (Bastani et al., 2010), breast cancer (Bastani et al., 1999), and
colorectal cancer (Bastani et al., 2001).
Participants: We collected qualitative data by interviewing Malawian
adult women (18 years of age and older) about their opinions and ex-
periences with cervical cancer disease and screening. To understand the
experiences of women who participate in “screen and treat,” we con-
ducted interviews immediately following this service; and to capture
the perspective of a broader cross-section of women (including those
who have never been screened), we interviewed women visiting the
facility for other types of care. Women in this latter group were only
eligible if they had heard of cervical cancer, as we wanted to interview
women with some awareness of the disease. We used convenience
sampling for both, and enrolled all eligible and willing women until
meeting the desired sample size of 10 women in each group, per fa-
cility. After being assessed for eligibility, women were given an op-
portunity to ask questions before providing oral informed consent to
participate in an interview. Data were collected anonymously. The in-
terview guides included semi-structured open-ended questions that re-
flected constructs of the MHOF.
Study sites: We conducted interviews with women at three health
facilities in Central Malawi that have implemented “screen and treat”
using thermocoagulation since 2015. Interviews were conducted be-
tween November 2018 and January 2019.
Data collection: Interviews were conducted by Malawian staff highly
experienced in qualitative data collection methods. The interviewers
were female, and received specific training for this project that included
an overview of cervical cancer disease and prevention, and extensive
training and pre-testing with the interview guides for this study. Based
on pilot testing of the interview guide, we made small adjustments to
clarify language (for example, to ensure that words like “screening” and
“cervix” were accurately communicated). The interviews were con-
ducted in Chichewa (the local language) and lasted on average 26 min
(median 24 min, range 15–55 min). The interviews were conducted in-
person, and with the participant’s consent, all interviews were audio
recorded. At the end of the interview, participants were given an op-
portunity to ask questions and provide any additional comments.
Participants were given 1500 Malawi kwacha (approximately US$ 2)
for their participation in the study.
Data analysis: All audio recordings were transcribed and translated
Fig. 1. Multi-Level Health Outcomes Framework (MHOF) with study-specific constructs highlighted in grey.
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to English by an experienced team of bilingual (Chichewa-English)
translators. A codebook was developed based on MHOF constructs, and
emergent codes were added as the codebook was pilot tested on several
transcripts. Two authors (CM and PK) refined the codebook through
three rounds of iterative coding, and when high inter-rater agreement
was reached, each independently coded a subset of the transcripts using
NVivo software (QSR International, v11).
Analysis focused on constructs within the “Patient” domain of the
MHOF. After coding the transcripts, text within each domain was read
for the identification of sub-themes; we then looked for similarities in
respondent demographics within each of these sub-themes – primarily,
whether the respondent had experience with cervical cancer screening
(the label “screening-inexperienced” was used for women who had
never been screened and those who were screened for the first time that
day), her self-reported HIV status, and her age.
Ethical review: This study was approved by the Institutional Review
Board at the University of California Los Angeles and the Malawi
National Health Sciences Research Committee.
3. Results
We conducted interviews with 60 women. No potentially eligible
participant was excluded due to not having heard of cervical cancer.
The average age of respondents was 39 years (Table 1). Approximately
half of women in the sample (n = 32, 53.3%) reported being HIV-
negative, while 41.7% were HIV-positive (n = 25), and 3 women did
not disclose their status. Only 13 women (21.7%) said they had never
been screened for cervical cancer, and 17 women (28.3%) were at the
facility that day for their first-ever cervical cancer screen; approxi-
mately one-quarter of these screening-inexperienced women (n = 8)
were HIV-positive and on ART. Half of the sample (30 women) reported
having been screened for cervical cancer at least once previously. Two
respondents spoke of being screened annually, and they both reported
being on ART.
Approximately half of the respondents said they had first heard of
cervical cancer within the last 5 years (n = 31), and half of these
women (n = 14) were HIV-positive. Ten women said they had first
heard within the last year, and most of these women were HIV-negative
(7 women). The most common sources for learning about cervical
cancer screening for the first time were the radio (mentioned by 25
women) and the health facility (mentioned by 24 women). Thirteen
women said they had heard through word of mouth, and some women
also cited other sources, such as church (mentioned by 4 women),
school, and announcements in the village.
3.1. Knowledge and beliefs
When asked whether they felt that cervical cancer was a dangerous
disease, most women responded in the affirmative. The most prevalent
reason was because of the risk of death, and this was mentioned by
women both experienced and inexperienced with screening. Put simply:
“Cancer kills, and it’s very dangerous” (54, on ART, twice screened).
Almost one-third of respondents (n = 18) mentioned knowing a
friend or family member who had cervical cancer, and some re-
spondents spoke about the prevalence of cervical cancer in Malawi as
reinforcing their opinion of its severity: “It is big because it’s ruining the
lives of many people in Malawi” (30, HIV-, once screened).
Women discussed their susceptibility to cervical cancer. Some HIV-
positive women acknowledged that they are at increased risk; this was
reported only among women experienced with screening, and primarily
among women over age 40. Inversely, some HIV-negative respondents
spoke about how exposure to information about cervical cancer had
corrected previous misconceptions [“I thought I was safe since I am not
HIV positive” (33, HIV-, first time screened)]. A few respondents said
they felt susceptible to cervical cancer because it is widespread [“Cancer
is an epidemic and cannot be avoided” (30, HIV-, once screened)].
Respondents commonly spoke of risk factors for cervical cancer, and
sexual transmission was the most commonly mentioned, particularly
among women experienced with screening. Women spoke of the im-
portance of reducing multiple sexual partnerships:
“We should abstain because sleeping with many men is one way of
getting this disease. We should be satisfied with the man that we have.” (59,
HIV-, twice screened)
Male circumcision, male hygiene, and use of vaginal herbs for
sexual pleasure were mentioned by several respondents as associated
with cervical cancer risk. Several women also spoke about how their
husbands’ sexual behavior would affect their own cancer risk:
“Since they say men can transmit the virus after having multiple part-
ners, that is where my worry is – that my husband may be the one to transmit
the virus.” (55, HIV-, never screened)
3.2. Cues to action
Women who were being screened for the first time were asked why
they had decided to get screened that day. Some women mentioned
wanting to know their “cancer status;” among HIV-positive women, this
motivation seemed tied to their perception of susceptibility:
“Many women are dying of cervical cancer, so I came so that I should
know my status on cancer.” (41, on ART, first time screened).
Several women mentioned feeling at risk – either due to specific
symptoms (primarily abdominal pain, as well as amenorrhea), or risk
factors (e.g., partner infidelity or a family history of cervical cancer).
Another common source of motivation for screening was urging from
friends or family. Some women spoke of accompanying a peer for
screening:
“On Monday, a neighbor asked me if I have screened for cervical
Table 1
Characteristics of the study population (n = 60), stratified by screening history.
Full sample (n = 60) Never screened (n = 13) First-time screeners (n = 17) Women screened at least once before (n = 30)
Age Mean: 39
Median: 40
Range: 18–62
Mean: 40
Median: 39
Range: 20–56
Mean: 38
Median: 39
Range: 18–56
Mean: 40
Median: 41
Range: 21–62
HIV status
Negative
Positive
Undisclosed
n = 32 (53.3%)
n = 25 (41.7%)
n = 3 (5.0%)
n = 8 (61.5%)
n = 3 (23,1%)
n = 2 (15.4%)
n = 10 (58.8%)
n = 6 (35.3%)
n = 1 (5.9%)
n = 14 (46.7%)
n = 16 (53.3%)
n = 0
Screening frequency n/a n/a n/a
Once
Twice
Three times
Four times
Annually
n = 15 (50%)
n = 9 (30%)
n = 2 (6.7%)
n = 2 (6.7%)
n = 2 (6.7%)
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cancer… She told me that she was afraid, and I encouraged her that we
should go and get screened. I came with her, so that we should get screened
and know the truth.” (53, HIV-, first time screened)
It was common for women to encounter multiple cues to action for
their first-ever screen, and many mentioned that their final decision to
get screened was motivated by community-based announcements with
specific information about services offered at a certain time and place.
“The campaign announcing about cervical cancer made me realize that
there is an opportunity for me to get screened.” (33, HIV-, first time
screened)
Women who had never been screened were asked if they had plans
to be screened in the future. All said that they planned to be screened;
the most common reason was to know one’s status (“Because I want to
know how I am” [23, on ART]). A few women cited concerns about
specific symptoms (“I wish to be screened because sometimes I have sto-
mach problems” [26, HIV-]), and several mentioned the importance of
screening as a regular health maintenance practice.
3.3. Barriers and supports
Many women spoke about the importance of early intervention to
mitigate the danger of death (i.e., screening to identify disease before it
has progressed, and therefore being able to access treatment). This was
mentioned by respondents of different ages, HIV status, and screening
history – including women who have never been screened:
“If they test you and find that you have cancer, they do cryotherapy to
kill the cancer cells. But when you are late and the cancer has spread, it has
no cure because it destroys the body inside so you die anytime.” (47, on
ART, never screened)
Screening-experienced women spoke about how screening alleviates
stress and uncertainty related to cervical cancer; and several women
spoke about how being screened for the first time altered this per-
spective:
“At first I used to think it was a big issue before I got screened. But now
that I got screened it is lighter because now I know about my health status
and where my future is.” (53, HIV-, first time screened)
Many respondents said they had heard rumors that screening is
painful and/or dangerous and that this had deterred them; this was
common among screening-inexperienced women:
“I heard that they insert a metal instrument with an appearance of a
duck mouth, and it hurts, and when you come back from the screening you
can’t sit. But then I realized that listening to other people will not help me,
and here I am able to sit after being screened, I am not even in pain.” (56,
HIV-, first time screened)
Additionally, issues of modesty were mentioned as a barrier by
women of all backgrounds (screening-experienced and -inexperienced
women, regardless of ages or HIV status):
“It’s so hard for a woman to undress for a man. It’s different from labor
when you are in pain and you just want to get helped. This is a different case
- you are okay, so for you to undress for a man, most women see it as a
wrong thing.” (39, HIV-, once screened)
Some women also mentioned that their husbands were not sup-
portive of screening, due in part to these modesty concerns or general
beliefs about gender norms and decision-making. There were also
concerns about the lesion removal technique – including about the re-
commended 4-week period of abstinence, and rumors that treatment
leads to infertility:
“After I was told that I have cancer signs and that they need to treat, I
went back home and people started saying that I will never again have any
more children and that they have seen people who have been treated from
lesions but they never gave birth again. My husband got scared and he asked
around to see whether that is true or not. Most responses told him that it’s
true so yesterday he came back home and said our marriage is over.” (23,
HIV-, once screened)
In other cases, women mentioned the importance of support from
their husbands:
“Going with your husband to screen for cervical cancer is not wrong… If
you are found VIA positive and your husband is there, you help each other
pass through the hard times.” (50, on ART, annual screener)
Women also spoke of the distance and cost of reaching the health
facility as a barrier to screening; long wait times and supply shortages;
and ill treatment by health care providers that discouraged them:
“Doctors should talk to us politely. Because sometimes they get tired and
they shout… that demotivates a lot of women from getting screened for
cervical cancer.” (31, HIV-, never screened)
“A doctor at [X Hospital] told me that the process is scary, in a way that
scared me so that I should not go get tested.” (23, on ART, never screened)
4. Discussion
Reflecting the high prevalence of invasive cervical cancer in
Malawi, women who were interviewed for this study saw cervical
cancer as dangerous and common – and many had lost friends or family
members to cervical cancer. Knowledge of the disease was universal,
and women were well-informed about its source as a sexually-trans-
mitted virus. Although half of the respondents were screening-in-
experienced (never screened or screened for the first time that day), all
women understood the benefits of screening and the importance of
identifying problems early, before cervical cancer has progressed. When
compared to earlier studies, this and another recent study from Malawi
(Maree and Kampinda-Banda, 2018) suggest trends of increasing
knowledge about cervical cancer and a heightened sense of suscept-
ibility (Fort et al., 2011; Hami et al., 2014; Ports et al., 2015).
Paralleling a broader literature from sub-Saharan Africa, we iden-
tified several barriers that may be contributing to the disconnect be-
tween high knowledge and low uptake of screening (Getachew et al.,
2019; Lieber et al., 2019; Olubodun et al., 2019) including hesitations
due to rumors about dangers and discomforts. Those who overcame this
barrier expressed eagerness to educate their friends and community
members about their experience. Some first-time screeners said they
came to be screened that day because they accompanied a friend or
neighbor. Other studies from sub-Saharan Africa have similarly iden-
tified the importance of interpersonal relationships for promoting cer-
vical cancer screening (Gatumo et al., 2018; Huchko et al., 2019;
Nyambe et al., 2019), which suggests an important potential area for
intervention. Participants articulated benefits of screening –the im-
portance of early detection and the psychological relief of knowing
one’s status – that may be appropriate messages for interventions.
Health system strengthening is a necessary accompaniment for any
cancer control strategy in a low-resource setting like Malawi
(Chidyaonga-Maseko et al., 2015; Finocchario-Kessler et al., 2016) and
health system factors were highly relevant determinants of screening in
this population – both positive (as a source of information about
screening in this population) and negative, such as long travel and wait
times, poor treatment by health workers, and shortages of screening
supplies.
A key benefit of the MHOF is its articulation of the distinct roles of
mutable and immutable constructs: mutable factors are amenable to
intervention, while immutable factors (like patient age or demo-
graphics) can inform the targeting or tailoring of interventions. Our
study adds to the relatively small literature about HIV-positive women’s
experiences undergoing cervical cancer screening (Finocchario-Kessler
et al., 2016; White et al., 2012). Taken together, these data suggest
ways in which HIV status may intersect with attitudes toward cervical
cancer: HIV-positive women cited their increased risk for cervical
cancer disease, and some first-time screeners who were HIV positive
mentioned this as a cue to action. On the other hand, some women said
they felt less susceptible to cervical cancer because they are HIV-ne-
gative. Future work might seek to develop unique messages for HIV-
negative women that clarify their cervical cancer risk.
Our study adds new evidence to the nascent literature about the
importance of male partner involvement in cervical cancer screening
C. Moucheraud, et al. Preventive Medicine Reports 18 (2020) 101093
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programs, and suggests ways to target interventions to both men and
women in order to ease communication between partners, reduce
misconceptions, and improve uptake of screening (Adegboyega et al.,
2019; Adewumi et al., 2019; Chidyaonga-Maseko et al., 2015; Lim and
Ojo, 2017; Manga et al., 2019; Ragan et al., 2018). This study identified
important information related to gender and sexuality, including con-
cerns about examinations by male doctors, lack of spousal support for
screening and/or lesion removal, concerns related to fertility and
childbearing, and sex-related risk behaviors.
Some limitations should be noted. First, all participants were re-
cruited from health facilities with established “screen and treat” pro-
grams, so these results should be interpreted in the context of access to
cervical cancer services and may not generalize to environments
without such services. Availability of “screen and treat” is far from
universal in lower-resource settings; per the Malawi National Cervical
Cancer Strategy, there are 129 VIA sites in Malawi, of which only 32
offer lesion removal (The Government of Malawi Ministry of Health,
2017). (For context, there are approximately 1000 health facilities in
Malawi (Ministry of Health Malawi and ICF International, 2014).) Ad-
ditionally, the sampling strategy resulted in a respondent pool with an
above-average HIV prevalence (the cervical cancer screening program
is funded by PEPFAR, and therefore is implemented at HIV treatment
sites, and this constituted the sampling frame for our study). Second,
responses may be subject to reporting bias, including recall bias (if
more dramatic incidents like negative experiences are recalled more
readily) and social desirability bias (if women feel pressure to say
certain things, e.g., about perceived severity of cervical cancer). All
interviews were conducted by highly experienced and well-trained
Malawian research assistants, and we tried to mitigate these sources of
bias by thoroughly probing all responses and establishing a good rap-
port with participants. Lastly, we did not collect additional socio-
demographic information on respondents so cannot compare findings
along such dimensions.
Interventions to improve screening coverage have largely focused
on increasing knowledge and expanding service availability. Cancer
control researchers, practitioners, and policymakers should augment
these efforts with interventions targeting other factors that may play a
crucial role for women, such as engaging social networks and educating
and including spouses/partners in the screening process. A compre-
hensive, multi-level approach will be needed if we want to make sub-
stantial gains in reducing the burden of cervical cancer in the most-
affected countries worldwide.
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